Xiaoyong Lu
88 Jiefang Road
Hangzhou, 310000, China
Hangzhou, 310000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
ALDH2 Ameliorates Acute Gouty Arthritis Through Inhibiting NLRP3 Inflammasome and Pyroptosis by Nrf2/ROS Pathway.
Journal: Journal of inflammation research
Published: May 09, 2025
Dietary anthocyanin is associated with a lower prevalence of hyperuricemia independently of metabolic syndrome among females: Results from NHANES 2007-2010 and 2017-2018.
Journal: International journal of rheumatic diseases
Published: February 19, 2024
A rare case of IgG4-related disease masquerading as periurethral malignancy and review of the literature.
Journal: Frontiers in immunology
Published: October 23, 2022
The role of gut microbiota in gout: Is gut microbiota a potential target for gout treatment.
Journal: Frontiers in cellular and infection microbiology
Published: September 23, 2022
Febuxostat Therapy for Patients with Gout and Stage 2-4 CKD: a Retrospective Study.
Journal: Rheumatology and therapy
Published: May 23, 2022
Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.
Journal: Frontiers in cell and developmental biology
Published: May 04, 2020
Vasoactive intestinal peptide-induced tolerogenic dendritic cells attenuated arthritis in experimental collagen-induced arthritic mice.
Journal: International journal of rheumatic diseases
Published: August 04, 2018
IL-1β functionally attenuates ABCG2 and PDZK1 expression in HK-2 cells partially through NF-ĸB activation.
Journal: Cell biology international
Published: July 06, 2018
Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.
Journal: Arthritis research & therapy
Published: July 28, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026